These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 25897062)

  • 21. Fake antimalarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake antimalarials.
    Dondorp AM; Newton PN; Mayxay M; Van Damme W; Smithuis FM; Yeung S; Petit A; Lynam AJ; Johnson A; Hien TT; McGready R; Farrar JJ; Looareesuwan S; Day NP; Green MD; White NJ
    Trop Med Int Health; 2004 Dec; 9(12):1241-6. PubMed ID: 15598255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poor-quality antimalarials further health inequities in Uganda.
    Evans DR; Higgins CR; Laing SK; Awor P; Ozawa S
    Health Policy Plan; 2019 Dec; 34(Supplement_3):iii36-iii47. PubMed ID: 31816072
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Falsified antimalarials: a minireview.
    Chaccour C; Kaur H; Del Pozo JL
    Expert Rev Anti Infect Ther; 2015 Apr; 13(4):505-9. PubMed ID: 25683870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Substandard artemisinin-based antimalarial medicines in licensed retail pharmaceutical outlets in Ghana.
    El-Duah M; Ofori-Kwakye K
    J Vector Borne Dis; 2012 Sep; 49(3):131-9. PubMed ID: 23135006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Substandard and Falsified Medicines: Influence of Different Tolerance Limits and Use of Authenticity Inquiries.
    Hauk C; Hagen N; Heide L
    Am J Trop Med Hyg; 2021 Mar; 104(5):1936-1945. PubMed ID: 33788775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of thin-layer chromatography to detect counterfeit sulfadoxine/pyrimethamine tablets with the wrong active ingredient in Malawi.
    Khuluza F; Kigera S; Jähnke RW; Heide L
    Malar J; 2016 Apr; 15():215. PubMed ID: 27075749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global scenario of counterfeit antimalarials: A potential threat.
    Arora T; Sharma S
    J Vector Borne Dis; 2019; 56(4):288-294. PubMed ID: 33269727
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The economic impact of substandard and falsified antimalarial medications in Nigeria.
    Beargie SM; Higgins CR; Evans DR; Laing SK; Erim D; Ozawa S
    PLoS One; 2019; 14(8):e0217910. PubMed ID: 31415560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Substandard and Falsified Antibiotics and Medicines against Noncommunicable Diseases in Western Cameroon and Northeastern Democratic Republic of Congo.
    Schäfermann S; Hauk C; Wemakor E; Neci R; Mutombo G; Ngah Ndze E; Cletus T; Nyaah F; Pattinora M; Wistuba D; Helmle I; Häfele-Abah C; Gross H; Heide L
    Am J Trop Med Hyg; 2020 Aug; 103(2):894-908. PubMed ID: 32394884
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Poor Quality Artemisinin-based Combination Therapy (ACT) Medicines Marketed in Benin Using Simple and Advanced Analytical Techniques.
    Yemoa A; Habyalimana V; Mbinze JK; Crickboom V; Muhigirwa B; Ngoya A; Sacre PY; Gbaguidi F; Quetin-Leclercq J; Hubert P; Marini RD
    Curr Drug Saf; 2017; 12(3):178-186. PubMed ID: 28625144
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality of Artemisinin-Containing Antimalarials in Tanzania's Private Sector--Results from a Nationally Representative Outlet Survey.
    Act Consortium Drug Quality Project Team And The Impact Study Team
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):75-86. PubMed ID: 25897065
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model.
    Jackson KD; Higgins CR; Laing SK; Mwila C; Kobayashi T; Ippolito MM; Sylvia S; Ozawa S
    BMC Public Health; 2020 Jul; 20(1):1083. PubMed ID: 32646393
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Got ACTs? Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries.
    O'Connell KA; Gatakaa H; Poyer S; Njogu J; Evance I; Munroe E; Solomon T; Goodman C; Hanson K; Zinsou C; Akulayi L; Raharinjatovo J; Arogundade E; Buyungo P; Mpasela F; Adjibabi CB; Agbango JA; Ramarosandratana BF; Coker B; Rubahika D; Hamainza B; Chapman S; Shewchuk T; Chavasse D
    Malar J; 2011 Oct; 10():326. PubMed ID: 22039838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Composition analysis of falsified chloroquine phosphate samples seized during the COVID-19 pandemic.
    Waffo Tchounga CA; Sacre PY; Ciza P; Ngono R; Ziemons E; Hubert P; Marini RD
    J Pharm Biomed Anal; 2021 Feb; 194():113761. PubMed ID: 33234414
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method.
    Opuni KF; Nettey H; Larbi MA; Amartey SNA; Nti G; Dzidonu A; Owusu-Danso P; Owusu NA; Nyarko AK
    Malar J; 2019 Dec; 18(1):403. PubMed ID: 31805937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Substandard antimalarials available in Afghanistan: a case for assessing the quality of drugs in resource poor settings.
    Lalani M; Kaur H; Mohammed N; Mailk N; Wyk AV; Jan S; Kakar RM; Mojadidi MK; Leslie T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):51-58. PubMed ID: 25897070
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A nationwide survey of the quality of antimalarials in retail outlets in Tanzania.
    Kaur H; Goodman C; Thompson E; Thompson KA; Masanja I; Kachur SP; Abdulla S
    PLoS One; 2008; 3(10):e3403. PubMed ID: 18923672
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    Ozawa S; Evans DR; Bessias S; Haynie DG; Yemeke TT; Laing SK; Herrington JE
    JAMA Netw Open; 2018 Aug; 1(4):e181662. PubMed ID: 30646106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.